Company News for Nov 12, 2024

Zacks

12 Nov 2024

ICL Group Ltd.’s (ICL) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.
Shares of $Aramark(ARMK-W)$ (ARMK) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.
AbbVie Inc.’s (ABBV) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials.
Shares of Sapiens International Corp. N.V. (SPNS) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AbbVie Inc. (ABBV) : Free Stock Analysis Report

Aramark (ARMK) : Free Stock Analysis Report

ICL Group Ltd. (ICL) : Free Stock Analysis Report

Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2482700968"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2482700968\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2482700968?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4LSyP71ZcbNSV.s5ZrKdnA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d12ae6d407957348a46f55b412dfc98","is_english":true,"pubTime":"2024-11-12 20:13","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2482700968","market":"us","top_or_hot":-1,"title":"Company News for Nov 12, 2024","media":"Zacks","content":"<html><body><ul>\n<li><span>ICL Group Ltd.’s (</span>ICL<span>) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.</span></li>\n<li><span>Shares of $Aramark(ARMK-W)$ (</span>ARMK<span>) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.</span></li>\n<li><span>AbbVie Inc.’s (</span>ABBV<span>) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials. </span></li>\n<li><span>Shares of <a href=\"https://laohu8.com/S/SPNS\">Sapiens International Corp</a>. N.V. (</span>SPNS<span>) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million. </span></li>\n</ul>\n<p>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report</p>\n<p>AbbVie Inc. (ABBV) : Free Stock Analysis Report</p>\n<p><a href=\"https://laohu8.com/S/ARMK\">Aramark</a> (ARMK) : Free Stock Analysis Report</p>\n<p>ICL Group Ltd. (ICL) : Free Stock Analysis Report</p>\n<p>Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report</p>\n<p>To read this article on Zacks.com click here.</p>\n<p>Zacks Investment Research</p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Company News for Nov 12, 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCompany News for Nov 12, 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-12 20:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/company-news-nov-12-2024-121300792.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ICL Group Ltd.’s (ICL) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.\nShares of $Aramark(ARMK-W...</p>\n\n<a href=\"https://finance.yahoo.com/news/company-news-nov-12-2024-121300792.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"https://finance.yahoo.com/news/company-news-nov-12-2024-121300792.html","article_id":"2482700968","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4LSyP71ZcbNSV.s5ZrKdnA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d12ae6d407957348a46f55b412dfc98"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482700968","pubTimestamp":1731413580,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"ICL Group Ltd.’s  shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.Shares of Aramark  fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.AbbVie Inc.’s  shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials.Shares of Sapiens International Corp. N.V.  plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Sapiens International Corporation N.V.  : Free Stock Analysis Report. To read this article on Zacks.com click here.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4139":"生物科技","LU0882574055.USD":"富达全球健康医疗A ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","BK4566":"资本集团","LU0861579265.USD":"联博低波幅策略股票基金A","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","LU0122379950.USD":"贝莱德世界健康科学A2","SPNS":"Sapiens International Corp","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4588":"碎股","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","ARMK":"Aramark","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","BK4581":"高盛持仓","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","LU1989773731.SGD":"CPR Invest - Education A2 Acc SGD-H","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4093":"化肥与农用药剂","BK4209":"餐馆","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","ABBV":"艾伯维公司","ICL":"以色列化学","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4023":"应用软件","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H"},"translate_title":"2024年11月12日公司新闻","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":1,"ARMK":0.9,"ICL":1,"SPNS":1},"content_text":"ICL Group Ltd.’s (ICL) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.\nShares of $Aramark(ARMK-W)$ (ARMK) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.\nAbbVie Inc.’s (ABBV) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials. \nShares of Sapiens International Corp. N.V. (SPNS) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million. \n\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAbbVie Inc. (ABBV) : Free Stock Analysis Report\nAramark (ARMK) : Free Stock Analysis Report\nICL Group Ltd. (ICL) : Free Stock Analysis Report\nSapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}